Roundhill GLP-1 & Weight Loss ETF Rating $23.86 -0.37 (-1.53%) As of 04/25/2025 02:53 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsRatingsBuy This Stock Roundhill GLP-1 & Weight Loss ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.OZEM Aggregate RatingModerate Buy 2.70Holdings in OZEM have an aggregate rating of Moderate Buy based on 207 analyst ratings issued in the past year covering 15 companies (69.1% of the portfolio).OZEM Aggregate Price Target$23.86High Prediction$23.86Average Prediction$23.86Low Prediction$23.86Holdings in OZEM have an aggregate price target of $23.86 and a range of $23.86 to $23.86 covering 15 companies (69.1% of the portfolio).OZEM Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy8 Moderate Buy rating(s)Hold2 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Roundhill GLP-1 & Weight Loss ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 15 OZEM Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings18.03%NVONovo Nordisk A/S$62.07-0.9%4.5155 of 5 stars2.25$135.00 117.5%12Analyst UpgradeGap Down15.17%LLYEli Lilly and Company$884.94+2.9%4.7967 of 5 stars2.89$1,017.00 14.9%19Upcoming EarningsAnalyst ForecastAnalyst Revision4.64%GPCRStructure Therapeutics$23.74+0.4%2.2474 of 5 stars3.00$81.29 242.4%8Analyst ForecastNews Coverage4.20%VKTXViking Therapeutics$24.99-2.6%4.2101 of 5 stars2.92$89.50 258.1%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage3.61%ALTAltimmune$5.07-1.9%2.3813 of 5 stars2.89$20.83 310.9%93.54%PFEPfizer$22.95+0.7%4.9948 of 5 stars2.53$29.57 28.9%17Upcoming EarningsDividend AnnouncementAnalyst ForecastAnalyst Revision3.15%AZNAstraZeneca$69.57+0.0%3.7165 of 5 stars3.10$88.00 26.5%10Upcoming EarningsAnalyst RevisionNews CoveragePositive News3.12%AMGNAmgen$280.84+0.4%4.6162 of 5 stars2.43$310.57 10.6%23Upcoming EarningsAnalyst ForecastAnalyst RevisionPositive News2.72%TERNTerns Pharmaceuticals$2.92-4.3%4.1874 of 5 stars2.60$18.38 529.3%5News CoveragePositive News2.29%REGNRegeneron Pharmaceuticals$602.64+0.5%4.804 of 5 stars2.88$945.32 56.9%26Upcoming EarningsAnalyst ForecastAnalyst Revision2.15%SRRKScholar Rock$32.81-4.6%4.0148 of 5 stars3.00$42.67 30.0%6News CoveragePositive News1.81%GILDGilead Sciences$103.17-2.8%4.5033 of 5 stars2.78$109.43 6.1%27Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionNews CoverageGap Down1.77%BHVNBiohaven$19.81-15.4%3.5622 of 5 stars3.07$62.77 216.9%15Analyst UpgradeOptions VolumeGap DownHigh Trading Volume1.68%RYTMRhythm Pharmaceuticals$63.76+1.3%3.8173 of 5 stars3.00$74.92 17.5%13News CoveragePositive News1.23%OPKOPKO Health$1.41-3.4%3.966 of 5 stars2.75$2.75 95.0%4Analyst ForecastNews Coverage This page (NYSEARCA:OZEM) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredTrump’s treachery Forget what the media tells you. Trump’s inner circle may be pushing a financial reset that mirrors moves from...Porter & Company | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roundhill GLP-1 & Weight Loss ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Roundhill GLP-1 & Weight Loss ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OZEM Stock Free OZEM Stock Alerts